Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other bacterial metabolic enzymes and proton gradient systems represent a heterogeneous group of targets essential for bacterial bioenergetics and homeostasis. This category primarily includes the ATP synthase complex, which synthesizes ATP driven by the proton motive force (PMF), and various components of the electron transport chain that maintain the electrochemical gradient across the bacterial membrane (Andries et al., 2005, Science). These systems are critical for the survival of both actively replicating and dormant bacteria, such as Mycobacterium tuberculosis, making them high-value targets for treating persistent infections (Zhang et al., 2003, Science). Drugs like bedaquiline specifically inhibit the mycobacterial ATP synthase, leading to rapid ATP depletion and bactericidal effects. However, because this is a broad classification rather than a single molecular entity, it encompasses diverse mechanisms ranging from the disruption of membrane potential to the inhibition of specific metabolic pathways. A significant challenge in targeting these systems is ensuring selectivity for bacterial proteins over human mitochondrial counterparts to avoid systemic toxicity (Fiorillo et al., 2021, Frontiers in Aging Neuroscience).
Inhibition of bacterial ATP synthase, disruption of the proton motive force (PMF), and interference with respiratory chain electron transport to deplete cellular ATP levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other bacterial metabolic enzymes and proton gradient systems.